Clinical trial
L-Arginine in Pre-Eclampsia
NCT00157521 · Mario Negri Institute for Pharmacological Research, Other · Completed
Key facts
| NCT number | NCT00157521 |
|---|---|
| Title | L-Arginine in Pre-Eclampsia |
| Official title | A Double-Blind, Randomized, Pilot Study to Explore Whether Enhancing L-Arginine Bioavailability by Oral Supplementation Increases NO Production and Prevents Peroxynitrite Generation in the Pre-Eclamptic Placenta |
| Lead sponsor | Mario Negri Institute for Pharmacological Research, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pre-Eclampsia |
| Intervention type | Drug |
| Interventions | L-arginine |
| Enrollment | 30 |
| Start date | Sep 1, 2002 |
| Completion | May 1, 2006 |
| First posted | Sep 12, 2005 |
| Last update posted | Dec 22, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: